Network for human genetics
The Novogenia corporate group goes back to the year 2001, when the first of its companies, GenoSense Diagnostics was founded in Vienna, Austria. Today, the Novogenia group consists of Austrian and German biotech companies that act as pioneers in the field of preventive genetic testing, molecular diagnostics of diseases, lifestyle genetic testing, and medical food supplements. Additionally, the Novogenia Group oﬀers the world’s largest laboratory network, with more than 100 medical and genetic laboratories, and a portfolio of more than 3,200 various medical genetic tests.
+ Automated high-tech genetic engineering lab, licensed to perform medical genetic testing.
+ A network of more than 100 medical and genetic laboratories.
+ Development of software systems for laboratory management and automation.
+ Offering the world’s largest portfolio of genetic tests, with over 3,200 diﬀerent tests.
+ More than 3,000 international physicians and hospitals, in over 30 countries.
The Novogenia Group consists of several companies in the field of human genetics, biotechnology, and food supplements. These companies include Genosense Diagnostics, the global pioneer in the field of preventive genetic testing, Novogenia, an innovative technology lab, DNA Plus, the European leader in the field of preventive and lifestyle genetic testing, GenomePlus, a company focused on dietary supplements and medical products manufacturing based on individual genetic data, CDEMAC, the neonatal screening laboratory, and the two marketing companies DNA Plus Middle East and AstraGenix, serving the Middle Eastern and the US markets respectively.
The Novogenia GmbH was founded by Dr. Daniel Wallerstorfer in 2009, in Austria, and received in the same year the license for medical genetic testing from the Federal Ministry of Health.
In 2011, the Novogenia GmbH created the Novogenia laboratory network. Within a short time, more than 100 medical genetic laboratories were added to this network, with a portfolio of more than 3000 various medical genetic testing.
In 2012, the Novogenia GmbH took over the worldwide pioneer in preventive genetic diagnostics, GENOSENSE Diagnostics GmbH, with more than eleven years of experience in this area.
In 2013, Novogenia prepared again to extend its portfolio in new business areas, such as dietary supplements based on genetic data. This project was launched in 2014.
Since 2014, we now differentiate between the two brands DNAnutriControl (lifestyle diagnostic genetic testing) and DNAhealthControl (medical genetic testing), which we sell throughout Europe in cooperation with our partners.
The Novogenia Group is one of Europe’s market leaders in lifestyle and genetic diagnostics and a global pioneer in preventive genetic diagnostics.
Laboratory and network
+ Extensive experience in prenatal screening, cytogenetics, molecular diagnostics, and genetic counseling.
+ Network of more than 100 laboratories and more than 1,000 doctors.
+ Several satellite laboratories for neonatal screening.
+ International laboratory units that can be set up anywhere depending on demand.
+ Experts with years of experience in the analysis of neonatal screening with subsequent medical counselling.
The main arguments
+ As a network with more than 100 international laboratories, we can choose the best analyses provider, guaranteeing a competitive service of the highest quality standards for each analysis.
+ German-Austrian service quality: our main laboratory is located in Austria, a country with one of the strictest laws on genetic engineering in Europe, meaning all medical genetic testing must be evaluated and approved by officials before their use. Therefore, the Austrian laboratories observe the highest quality standards at international level as well.
+ Intelligently designed laboratory management and automation software ensures optimal data protection and prevents errors.
+ The laboratory is certified by the government to perform medical genetic analyses.
+ All genetic tests are carried out according to ISO 15189 standard for medical and genetic laboratories.
+ Austria operates with stringent regulations regarding genetic testing, to ensure that the patients benefit from the highest quality standards.
+ Novogenia is fully licensed to perform medical and genetic analyses.
+ Certification of certain satellite laboratories:
ISO 9001: 2008 – Provision of services in the field of genetic screening & testing
+ Certified for medical and genetic analyses
+ Quality control of certain satellite laboratories: Six Sigma
+ Highly automated laboratory
+ Barcode tracking of samples
+ Fingerprint access restrictions
+ Highly secure computer system
+ Automated DNA extraction and analysis processes
Capacity: 7,000 to 54,000 tests per month (24/7 automated laboratory analysis operation)
What makes us special – The advantages of Novogenia
FULL STATEMENT OF
DR. DANIEL WALLERSORFER
‘’In 2001, with the completion of the Human Genome Project, we first got an insight into the entire blueprint of the human body. Since then, genetics science has grown exponentially, and we now understand a great deal about the genetic basis of diseases, the effects of drugs, the important nutrients, and the causes and differences in skin aging.
So far genetics has been an innate fate to live with. Meanwhile, we know enough about it to intervene in these processes. With Novogenia we have set ourselves the goal of enabling people to take a look into their genome, to discover the reason for their own uniqueness and, above all, to achieve specific goals with this knowledge. Medication intolerances, which until now have simply occurred by chance and are one of the leading causes of death, can now be easily anticipated and avoided. Disease risks are detected in advance and can be effectively combated. Likewise, it is finally possible to find out how your body reacts to nutrients and calories and how to really feed yourself optimally. With this knowledge, innate weaknesses have become the real strengths in personalized nutrition and disease prevention’’